Ultragenyx Pharmaceutical Inc. (RARE) Social Stream



Ultragenyx Pharmaceutical Inc. (RARE): $39.22

-0.61 (-1.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RARE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 378

in industry

ULTRAGENYX PHARMACEUTICAL INC (RARE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RARE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-05 16 $185 $73 $146.2 $37.81 286.67%
2022-01-11 16 $185 $73 $143.933 $37.81 280.67%
2022-01-25 16 $185 $73 $143 $37.81 278.21%
2022-01-26 16 $185 $73 $142.4 $37.81 276.62%
2022-01-31 16 $185 $73 $140 $37.81 270.27%
2022-02-11 16 $185 $73 $140 $37.81 270.27%
2022-02-14 15 $185 $73 $139.466 $37.81 268.86%
2022-04-26 15 $186 $73 $139.533 $37.81 269.04%
2022-04-28 15 $186 $73 $139.666 $37.81 269.39%
2022-05-05 15 $186 $73 $138.461 $37.81 266.2%
2022-05-09 13 $186 $71 $129.538 $37.81 242.6%
2022-05-18 13 $186 $71 $126.846 $37.81 235.48%
2022-05-24 14 $186 $71 $125 $37.81 230.6%
2022-07-28 13 $185 $70 $121.5 $37.81 221.34%
2022-08-01 14 $185 $68 $117 $37.81 209.44%
2022-08-02 14 $185 $60 $112.666 $37.81 197.98%
2022-08-13 14 $185 $60 $114.5 $37.81 202.83%
2022-09-17 13 $185 $60 $117.266 $37.81 210.15%
2022-10-12 11 $185 $60 $117.266 $37.81 210.15%
2022-10-21 13 $185 $50 $112 $37.81 196.22%
2022-10-25 13 $185 $50 $111.5 $37.81 194.9%
2022-11-03 14 $164 $49 $102.312 $37.81 170.6%
2022-11-04 14 $143 $49 $98.125 $37.81 159.52%

The Trend in the Analyst Price Target


Over the past 52 weeks, RARE's average price target has gone down $45.2.

RARE reports an average of 130.25% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-01-26 16 185 73 142.400 68.11 109.07%
2022-04-19 15 186 73 139.533 78.10 78.66%
2022-08-02 14 185 60 112.666 51.28 119.71%
2022-10-13 13 185 50 112.000 39.65 182.47%
2022-10-25 13 185 50 111.500 39.39 183.07%

RARE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.46 10 1 3 0 0 14

The Trend in the Broker Recommendations


Over the past 123 days, RARE's average broker recommendation rating improved by 0.19.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of stocks in the large market cap category, ULTRAGENYX PHARMACEUTICAL INC's upside potential (average analyst target price relative to current price) is higher than 2526.4% of them.
  • ULTRAGENYX PHARMACEUTICAL INC's number of analysts covering the stock is greater than 2425.59% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, ULTRAGENYX PHARMACEUTICAL INC's average analyst price target is greater than 2394.48% of them.
  • ULTRAGENYX PHARMACEUTICAL INC's variance in analysts' estimates is lower than -2247.59% of stocks in the large market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ULTRAGENYX PHARMACEUTICAL INC are ALKS, ALNY, and UTHR.

What is the outlook for RARE? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.749 seconds.